Staphylococcus aureus is one of the most common causes of nosocomial infections, especially pneumonia, surgical site infections and blood stream infections and continues to be a major cause of community-acquired infections. Methicillin-resistant S. aureus (MRSA) was first detected approximately 40 years ago and is still among the top three clinically important pathogens 
numbers of reports indicating the emergence of vancomycin-resistant S. aureus (VRSA) strains exhibiting two different resistance mechanisms. Initially vancomycin-intermediate S. aureus (VISA) noted in Japan in 1996 and subsequently in United States in 1997, was believed to be due to the thickened cell wall 5 , where many vancomycin molecules were trapped within the cell wall. The trapped molecules clog the peptidoglycan meshwork and finally form a physical barrier towards further incoming vancomycin molecules 6 . The aim of the present study was to identify the emergence of vancomycin resistant MRSA among S. aureus isolates from tertiary care hospitals in Hyderabad, south India, and to determine the sensitivity of these isolates to different antimicrobial agents. Further search is also conducted for the vanA gene in VRSA strains. 
Material & Methods

Antibiotic susceptibility testing:
The antibioticresistance profile was determined by the disc agar diffusion (DAD) technique using different antimicrobial agents; penicillin G (10 U), oxacillin (1 µg), methicillin (30 µg), ampicillin (10 µg), ceftazidime (30 µg), gentamicin (10 µg), clarithromycin (15 µg), erythromycin (15 µg), clindamycin (2 µg), co-trimoxazole (25 µg), chloramphenical (30 µg), rifampin (5 µg), tetracycline (30 µg) (Hi-media,
Mumbai) according to the guidelines recommended by Clinical and Laboratory Standards Institute (CLSI)
16 . Resistance to the aminoglycoside streptomycin was assessed similarly but the results were interpreted as per the guidelines of the manufacturer (Hi-Media). The standard S. aureus strains NCTC 12493 and ATCC 29213 were used as reference strains (department of microbiology, University of Gulberga) for MRSA and VSRA, respectively.
Determination of MIC:
Minimal inhibitory concentration (MIC) of vancomycin was determined by agar dilution method using CLSI guidelines
16
. Briefly, gradient plates of Mueller-Hinton agar (Hi-media) were prepared with vancomycin (0.5-256 mg/l, SigmaAldrich). 0.5 McFarland equivalent inoculum prepared using 18-24 h old culture was spotted on to gradient plates. Plates were incubated overnight at 35 o C for 24 h before assessing the visible growth.
PCR amplification for van A:
The primer synthesis and the PCR amplification of the vanA were done at Bioserve Biotechnologies, Hyderabad, using Gene Amp (Applied Biosystems, USA) thermocycler. The primers and the PCR conditions were as described 17 . The primers for amplification of vanA were; Forward ATGAATAGAATAAAAGTTGC and Reverse TCACCCCTTTAACGCTAATA. The amplification conditions were initial denaturation at 98 o C for 10 sec, annealing at 50 o C for 1 min, polymerization at 72 o C for 1 min; and final extension at 72 o C for 5 min.
Results
Among the 358 clinical isolates of S. aureus, 285 (79.6%) were identified as methicillin resistant S. aureus (MRSA) by disc diffusion method.
The MIC for 335 of 358 isolates (93.57%) for vancomycin was ≤2 mg/l indicating that all were sensitive to vancomycin. Sixteen isolates showed an MIC range between 4-8 mg/l, indicating vancomycin intermediate resistance. For the remaining seven isolates, the MIC was in the range of 16-64 mg/l indicating that these seven isolates were vancomycinresistant (VRSA). These were all MRSA and resistant to majority of the other antibiotics tested. All these seven isolates showed resistance to a minimum of six other antibiotics including vancomycin and methicillin (Table) .
One isolate of S. aureus had vancomycin MIC of 4 mg/l and considered VISA according to recent CLSI breakpoints for vancomycin. However, this isolate was not distinguished from vancomycin susceptible S. aureus in the disc diffusion test because it has shown >20 mm zone of inhibition. All isolated VRSA were resistant to ceftazidime, rifampicin, and were inducible for clindamycin resistance. About 86 per cent of the isolates were susceptible to tetracycline and 71.4 per cent each were susceptible to chloramphenicol and clarithromycin.
PCR amplification for vanA among the seven VRSA showed that six contained vanA, whereas all the isolates expressed mecA (unpublished data). One VRSA isolate was negative for vanA by PCR (Fig.) .
Discussion
Infections caused by methicillin-resistant S. aureus have been associated with high morbidity and mortality rates. In Indian hospitals, MRSA is one of Vancomycin-resistant S. aureus tend to be multidrug resistant against a large number of currently available antimicrobial agents, compromising treatment options and increasing the likelihood of inadequate antimicrobial therapy and increase in morbidity and mortality
24
. In the present study, VRSA showed resistance to a wide range of antimicrobial agents. Though all the isolates were phenotypically sensitive to clindamycin, these showed inducible clindamycin resistance. This may be due to the increased use of antibiotics in the intensive care units. Linezolid and quinupristin/dalfopristin were recently approved by the In conclusion, the results of this study showed the occurrence of vanA gene-negative VRSA in south India. The increase of vancomycin resistance among MRSA and excessive use of antimicrobial agents have worsened the sensitivity, which call for further epidemiological studies.
